Who Just Raised

Lexaria Bioscience Corp.

Kelowna, British Columbia, Canada ยท Biotechnology

Lexaria Bioscience Corp. is a biotechnology company based in Kelowna, British Columbia, Canada. In a Form D filed with the SEC on September 21, 2026, it reported raising $113,492 from 3 investors as part of an offering of up to $113,492. The first sale in the offering took place on September 9, 2026.

100% of the $113K offering sold so far

Lexaria Bioscience Corp.'s DehydraTECH improves the way APIs enter the bloodstream by promoting more effective oral delivery.

Website
lexariabioscience.com
Amount raised
$113,492
Offering size
$113,492
Investors so far
3
First sale
September 9, 2026
Securities offered
Options or warrants
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
Kelowna, British Columbia, Canada
Incorporated
Nevada
Entity type
Corporation
Revenue range
$5,000,001 - $25,000,000

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $113,492 $113,492 3 SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Other health care raises

Company Location Sector Raised Target Filed
Curadel Surgical Innovations, Inc. Bonita Springs, FL Health Care $49.8M $57.5M
Axelyf, Inc. Chestnut Hill, MA Health Care $2.6M $2.7M
iPill Inc. Rowland Heights, CA Health Care $1.3M $1.5M
Dvant Pharma, Inc. Superior Township, MI Health Care $1.2M $3.1M
FibroBiologics, Inc. Houston, TX Health Care $1.2M $1.2M
Vimy Pharmaceuticals Inc. Toronto, Ontario, Canada Health Care $1M $1M